Keywords: R&D innovaton, Biotech, EuropaBio, Tax, Financial and regulatory framework, Health technology assessment, HTA

European governments must ensure R&D is converted into new businesses, new products

Article | 27 March 2012

National governments in Europe need to do more to ensure that R&D innovation in the biotech industry is ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in